5 results
Experience
AstraZeneca LP v. SigmaPharm Laboratories AstraZeneca LP v. SigmaPharm Laboratories
1:15-cv-01000, D. Del., Judge Andrews
Experience
District court ruling maintains patent protection of Forest’s Savella® District court ruling maintains patent protection of Forest’s Savella®
1:13-cv-01602, D. Del., Judge Robinson
Practice
Branded Hatch-Waxman (ANDA) Litigation and Trials Branded Hatch-Waxman (ANDA) Litigation and Trials
Success in Abbreviated New Drug Application (ANDA) litigation in the U.S. often begins months or even years before a case is filed. Whether you are anticipating receipt of a Paragraph IV notice letter or still in late-stage clinical trials, it is never too early to start preparation.
Experience
District court ruling maintains patent protection for Allergan’s Saphris® District court ruling maintains patent protection for Allergan’s Saphris®
1:14-cv-01119, D. Del., Judges Fallon, Goldberg, Robinson
Practice
Global IP Enforcement, Litigation, and Trials Global IP Enforcement, Litigation, and Trials
When your company is facing an intellectual property-related dispute, either as the IP owner enforcing your rights or as the accused party, the stakes can be staggering—both financially and in the marketplace. A loss may even put an end to your business. You need an informed risk calculation. You need seasoned IP litigators who bring multifaceted and strategic insight...
3 results
Press Release
62 Finnegan Attorneys Named to 2018 Capital Pro Bono Honor Roll 62 Finnegan Attorneys Named to 2018 Capital Pro Bono Honor Roll
April 5, 2019
Press Release
48 Finnegan Attorneys Named to 2017 Capital Pro Bono Honor Roll 48 Finnegan Attorneys Named to 2017 Capital Pro Bono Honor Roll
February 20, 2018
Press Release
42 Finnegan Attorneys Named to 2016 Capital Pro Bono Honor Roll 42 Finnegan Attorneys Named to 2016 Capital Pro Bono Honor Roll
February 17, 2017
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.